THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
STAKEHOLDER FORUM 2015 - SAVE THE DATE
This year's IMI Stakeholder Forum will take place on Monday 15 June in Brussels, Belgium.
Join us to learn about IMI's achievements so far and give input on our future activities and plans!
- 28/04/2015 : RT @IMI_LifeTrain: The first series of student presentations at the #emtrainphd workshop demonstrated the strength and breadth of the scien…
- 28/04/2015 : RT @TheHyveNL: Alignment of the #tranSMART roadmap for @IMI_JU projects going on at @imperialcollege: here our CEO on architecture. http://…
- 28/04/2015 : RT @Alfons_Valencia: Martín Krallinger's PhD thesis defence (amazing work!). Text mining in biomed, LIMTOX. @CNIO_Cancer #eTOX http://t.co/…